Previous 10 | Next 10 |
2023-12-11 08:11:03 ET Summary US sectoral flows for November 2023 analyzed for impact on markets in December. Whopping $363 billion private sector surplus pointing to better markets in December. Fiscal flows expected to continue funding the economy and feeding the bull market...
2023-12-09 03:00:00 ET Summary The global markets experienced high volatility in 2023 due to factors such as high interest rates, bank failures, and a surge in bond yields. The macro environment in 2024 is expected to be complex and interesting, with rewards for investors who are ...
2023-12-04 08:13:57 ET More on market strategy Bears Refuse To Acknowledge New All-Time Highs In 2024 SPY Is A Buy According To The 200-Day Simple Moving Average When Do You Take Profits? S&P 500 hits new 2023 closing high to end week in which it notched ...
2023-11-23 01:39:17 ET Summary Shares of iShares Biotechnology ETF have been trading below their 40-month moving average for almost two years, indicating potential downside risk. The bearish divergences in the fund's RSI momentum indicator and MACD suggest a retest of the multi-ye...
2023-11-22 02:15:00 ET Summary Q3 earnings season had many familiar refrains relative to the year’s first two quarters. One difference was a return to positive earnings growth for the first time since Q3 2022. Not unlike the first two quarters of the year, earnings for ...
2023-11-21 21:11:32 ET Summary Tech-related stocks have performed poorly in 2023, with small-sized funds experiencing even worse losses. The iShares Biotechnology ETF and the SPDR S&P Biotech ETF have performed similarly so far in 2023. IBB is a large ETF with exposure to ...
2023-11-21 09:05:00 ET Summary A more volatile macroeconomic regime, alongside relatively high rates, may mean investors need to demand greater compensation for taking on equity risk; they can meet this higher performance bar by getting precise about targeted opportunities. The AI...
2023-11-20 00:24:09 ET Summary Biotech stocks have been heavily impacted by rising interest rates and the disruption caused by FTC-challenging acquisitions of biotechs. The equal-weight biotech ETF (XBI) has shown signs of a rebound after a prolonged downtrend, potentially due to ...
2023-11-17 05:55:00 ET Summary Biotech sector faces challenges including higher interest rates, inflation, regulatory pressures, and a post-COVID slump. Short interest remains high for some pharmaceutical companies, indicating bearish sentiment. Exchange-traded funds in the bi...
2023-11-15 08:16:54 ET More on Markets Oppenheimer favors tech amid upbeat prediction for S&P 500 Cathie Wood's ARK Invest launches crypto ETFs in partnership with 21Shares Nasdaq exits correction territory, small caps rebound in Russell revenge For furth...
News, Short Squeeze, Breakout and More Instantly...
iShares Biotechnology ETF Company Name:
IBB Stock Symbol:
NASDAQ Market:
2024-06-28 22:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-28 08:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...